FDA
-
-
-
-
-
-
-
ImpediMed Announces U.S. Launch of Lymphedema Prevention Program with GenesisCare a Global Organization Dedicated to Care of Cancer Patients
-
-
-
-
-
-
-
ImpediMed Announces Presentation at Heart Failure Society of America Annual Scientific Meeting That Demonstrates Utility of SOZO® Digital Health Platform for Heart Failure Patients
-
-
-
-
-
-
-
ImpediMed Announces Ambitious New Program Aimed at Ending Cancer-Related Lymphedema
-
-
-
-
-
-
-
ImpediMed Highlights Publication of Recommendations in New England Journal of Medicine: Supports Use of Bioimpedence and L-Dex Measurement for Lymphedema Assessment
-
-
-
-
-
-
-
ImpediMed Vice President Dennis Schlaht Receives 2018 Advocate Award from Lymphatic Education & Research Network
-
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

